| Title: | The Dividing Line Between the Role of the FDA and the Practice of Medicine: A Historical Review and Current Analysis |
| Author: | Berry, Carol R. |
| Citation: | The Dividing Line Between the Role of the FDA and the Practice of Medicine: A Historical Review and Current Analysis (1997 Third Year Paper) |
| Full Text & Related Files: |
cberry.pdf (300.0Kb; PDF)
cberry.rtf (159.1Kb; RTF file)
cberry.html (119.0Kb; HTML)
|
| Abstract: | Over the years, the Food and Drug Administration ("FDA") has consistently asserted that it does not regulate the practice of medicine (the "Practice of Medicine Exception") . This prohibition has never been specifically set forth in the statutory scheme which guides the FDA's action. However, the Practice of Medicine Exception has been inferred from the Congressional intent expressed in the legislative history. Although the FDA purports to maintain this exception, the reality is that agency action certainly affects medical practice. |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846812 |
Contact administrator regarding this item (to report mistakes or request changes)